Evidence map›Paper›PMID 42058115›Full record

ArticleKidney international reports2026

Pilot Study of Diagnostic Performance of Serum Creatinine/Cystatin C Ratio for Pseudo-AKI.

Ran Jiang, Yafeng Huang, Lingling Deng, Lu Yang, Huijuan Mao, Buyun Wu

Abstract read
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ran JiangDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
Yafeng HuangDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
Lingling DengDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
Lu YangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
Huijuan MaoDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.
Buyun WuDepartment of Nephrology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We conducted a proof-of-concept study to evaluate the diagnostic performance of the serum creatinine/cystatin C ratio (CrCyR) in distinguishing pseudo-acute kidney injury (AKI) from true AKI. Methods: This study included patients with confirmed AKI (excluding rhabdomyolysis) at the First Affiliated Hospital of Nanjing Medical University (May 2023-August 2024) and pseudo-AKI cases identified through a literature review (1994-2025). CrCyR values (unit: l/dl) measured before (CrCyR Results: Of the 239 patients, 197 had true AKI and 42 had pseudo-AKI (mechanisms: reduced creatinine excretion [ Conclusion: CrCyR

Indexed as

acute kidney injurydiagnostic efficacypilot studypseudo-acute kidney Injuryserum creatinine/cystatin C ratio

Identifiers

PMID42058115
PMCPMC13123345

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.